Study summary

A drug designed by generative AI reached human testing and showed early promise

AI-discovered drug trial · Phase 2a, small · Published June 2025, Nature Medicine

What was tested

A TNIK-blocking pill, discovered using generative AI rather than traditional drug screening, against placebo, in an early trial.

What they found

The AI-designed drug showed signs of slowing fibrosis markers in this early trial.
It moved from AI design to human testing faster than a typical drug.

What it means

An early proof that AI-discovered drugs can reach real patients; still needs larger, longer trials.

Nat Med, via PubMed ↗ ← Back to the outlook

Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.